Diagnostic Performance of Serum Human Epididymis Protein 4 in Endometrial Carcinoma: A Pilot Study

Journal Title: Journal of Clinical and Diagnostic Research - Year 2017, Vol 11, Issue 7

Abstract

Introduction: Endometrial Cancer (EC) is a common female malignant disorder. To date, there are no specific tumour markers for EC that may be routinely used in clinical practice for diagnosis. Aim: To evaluate the diagnostic performance of the serum Human Epididymis protein 4 (HE4) as biomarker for EC and to determine its association with clinicopathological variables. Materials and Methods: The study population included 60 postmenopausal women with a diagnosis of EC and 60 healthy postmenopausal female subjects (control group). Concentrations of serum HE4 and CA-125 in EC patients and control group were determined using Enzyme-Linked Immunosorbent Assays (ELISA). The value of serum HE4 and CA-125 for the diagnosis and prediction of stage, histology, myometrial invasion and lymph nodal metastasis was analysed. Results: The mean serum HE4 and CA-125 levels were significantly higher in patients with EC than those with control group (p<0.05). Comparison for HE4 and CA-125 between different stages showed a statistically significant difference. Stage I EC patients with <50% myometrial invasion had a significantly lower mean serum HE4 value than patients with >50% myometrial invasion (p=0.007). Corresponding values of CA-125 showed a similar trend (p=0.023). There were significantly higher levels of HE4 and CA-125 in cases with lymph node involvement. The levels of serum HE4 and CA-125 were higher in the non-endometroid histology, but the difference was not statistically significant. The Receiver Operating Characteristics (ROC) curve analysis for EC and control group showed that HE4 had greater Area Under Curve (AUC) when compared with CA-125. Using ROC curve, a serum HE4 concentration of 69.8 pmol/l (AUC 0.974) and/or serum CA-125 level of 34.50 U/mL (AUC 0.714) was used to predict malignancy. Sensitivity of combined biomarkers showed no additional improvement in comparison to HE4 or CA-125 alone. Conclusion: Our results show that HE4 is a sensitive diagnostic serum marker for detection of EC patients, exhibiting a better diagnostic performance compared to CA-125. Good performance of HE4 in diagnosis of early stages EC indicates its usefulness as a prognostic marker and also to monitor therapy and detect early recurrence.

Authors and Affiliations

Rupali Dewan, Abhinav Dewan, Swati Hare, Mausumi Bhardwaj, Krati Mehrotra

Keywords

Related Articles

Can Bohler’s Angle Predict the Functional Results of Intra-Articular Displaced Calcaneal Fractures?

ABSTRACT Introduction: Intra-articular fractures need to be anatomically reduced. In intra-articular calcaneal fractures, Bohler’s angle can be used as a tool to achieve articular congruity intraoperatively. But a debate...

Gender Determination of an Individual by Scapula using Multi Detector Computed Tomography Scan in Dakshina Kannada Population-A Forensic Study

ABSTRACT Introduction: Gender is the most vital segment of the biological characteristics which can be evaluated from the skeleton because of the marked sexual dimorphism of bone segments. The bone examined in present st...

Analysis of Salivary Protein Profiles and its Viscosity in Early Childhood Caries (A Cross-Sectional Study)

ABSTRACT Introduction: Early Childhood Caries (ECC) affects a significant proportion of the child population worldwide. Salivary proteins contain a host defense system that plays a role in the caries pathogenesis. Aim: T...

Effect of Occupational Noise Exposure on Sleep among Workers of Textile Industry

ABSTRACT Introduction: Occupational noise exposure is one of the main risk factor that affects the health and sleeping pattern of the workers. Textile machines produce a high level of noise that can cause adverse health...

Dapsone Hypersensitivity Syndrome: A Potentially Fatal Condition – Case Report

Dapsone, an antimicrobial and anti-inflammatory drug, has wide applications. Dapsone Hypersensitivity Syndrome (DHS) is an Adverse Drug Reaction (ADR) ranging from mild cutaneous manifestations to severe life-threatening...

Download PDF file
  • EP ID EP356363
  • DOI 10.7860/JCDR/2017/28926.10285
  • Views 92
  • Downloads 0

How To Cite

Rupali Dewan, Abhinav Dewan, Swati Hare, Mausumi Bhardwaj, Krati Mehrotra (2017). Diagnostic Performance of Serum Human Epididymis Protein 4 in Endometrial Carcinoma: A Pilot Study. Journal of Clinical and Diagnostic Research, 11(7), 1-5. https://europub.co.uk/articles/-A-356363